The Global Digital Pathology Market held USD 4.96 billion in 2019 and is predicted to reach USD 17.28 billion by 2030 with a CAGR of 11.9% from 2019-2030.
Digital pathology is also known as digital imaging, virtual slides, or virtual microscopy. It is a dynamic and image-based environment that allows procurement, administration, and interpretation of pathological information to computer screen. It enables the pathologist to observe the slide under a microscope and have digitalized image of it by using image analysis software. The adoption of the digital pathology has increased in numerous applications that includes diagnosis of the diseases, drug discovery, and research. In addition, rising occurrence of chronic conditions has increased the demand for the digital pathology, thereby impacting the digital pathology market share in future. Also, digital pathology provides live and high resolution images that helps the pathologist to provide better diagnosis.
Access Full Description of this report at:-
Top Companies: Nikon Corporation, PerkinElmer, Inc., Indica Labs, Inc., Koninklijke Philips N.V., Pixcelldata Ltd., Glencoe Software, Inc., Hamamatsu Photonics K.K., Visiopharm A/S, Danaher Corporation, Digipath Inc and others.
The digital pathology market is segmented on the basis of product, type, end user, application, and geography. On the basis of product, the market is segmented into scanner, software, storage systems, and communication system. On the basis of type, the market covers human and veterinary. On the basis of end user, the digital pathology market is classified into pharmaceutical & biotechnology companies, hospital & reference laboratories, and academic & research institutes. On the basis of application, the market is divided into teleconsultation, disease diagnosis, and drug discovery. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising North America, Europe, Asia-Pacific, and LAMEA.
Request sample copy of this report at:-
North America is anticipated hold the highest market share during the forecast period. This is attributable to the factors including denotes a higher adoption of the digital pathology, R&D investments, presence of major players, and high consumer awareness. It is expected that the emerging economies, specifically in the Asia-Pacific region would witness increasing market size owing to improvement in healthcare facility, proliferation of advanced imaging modalities in emerging economies, and untapped opportunities.
About Next Move Strategy Consulting:
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.
For more insights, please visit, https://www.nextmsc.com